Machine Learning

A novel sputum test could end the trial-and-error approach for millions with chronic respiratory disease, promising a new era of personalized medicine.

MacPaw's Setapp moves beyond its bundle model, offering single-app sales in a strategic pivot that empowers users and courts disgruntled developers.

CTL appoints Dan Rodgers, a finance leader from Nike and PwC, to pivot its financial strategy towards aggressive, sustainable growth in the tech lifecycle market.

With a soaring stock and a breakthrough CAR-T therapy, Immix Biopharma is set to capture investor attention. What's behind the hype for its lead drug, NXC-201?

A new AI tool clarifies accented English for listeners in real time, sparking both excitement for global business and debate over cultural identity.

A new partnership leverages advanced AI and metabolomics to find novel drug targets for rare metabolic disorders, offering new hope for millions worldwide.

A new deal brings Nanox's low-radiation, cost-effective Nanox.ARC to orthopedic clinics, aiming to reshape point-of-care diagnostics in the region.

An AI firm known for fighting cancer is now partnering with Unilever, signaling a new era of biologically personalized consumer products and new ethical questions.

A 30-year study reveals massive ice loss, with commercial satellites providing an unprecedented, all-weather view of our planet's changing climate.

Amid a strategic overhaul, Hepion Pharmaceuticals is licensing a novel RNA-based liquid biopsy, aiming to transform early liver cancer detection.

A novel drug delivery system could revolutionize Alzheimer's treatment, and Acumen Pharmaceuticals is leading the charge with its targeted therapy.

A new report reveals 87% of firms use AI in customer education, but a dangerous lack of strategy and governance threatens quality, security, and ROI.

A new AI reasoning agent promises to move telcos toward Level 4 autonomy, automating complex network operations and boosting efficiency.

As AI reshapes software, Tricentis is taking its Transform conference global, pushing a new paradigm of 'agentic quality engineering.' Here's what it means.

Former Novo Nordisk CSO Marcus Schindler joins Cradle, validating AI's role in accelerating drug discovery and reshaping traditional pharmaceutical R&D.

After a kidney trial setback, CalciMedica's lead drug Auxora shows strong promise for acute pancreatitis, but a tight cash runway looms over its future.

A new report shows fraud fears in private credit are soaring, fueled by AI and bankruptcies, but data reveals a different story for secured lenders.

EyeMD EMR rebrands as Optivate, launching a unified, AI-driven platform. This move signals a new chapter for eye care practice management.

Creality's new Sermoon P1 combines standalone processing and multi-mode lasers, offering industrial-grade 3D scanning at a disruptive price point.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.